NCT06374030 Retrospective Study of Airway Management in Dutch ED's
| NCT ID | NCT06374030 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Frisius Medisch Centrum |
| Condition | Endotracheal Intubation |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2019-01-01 |
| Primary Completion | 2023-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2019-01-01 with a primary completion date of 2023-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Describing characteristics of the practice of airway management in Dutch emergency departments, including information about patient demographics, indications, performer characteristics, equipment and medication used and complications due to intubation.
Eligibility Criteria
Inclusion Criteria: * All patients who underwent endotracheal intubation between 01-01-2019 and 31-12-2023 in the participating ED's Exclusion Criteria: * Patients for which no information about the intubation can be found in the electronic patient chart will be excluded from the study.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06374030 clinical trial?
This trial is open to participants of all sexes, studying Endotracheal Intubation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06374030 currently recruiting?
Yes, NCT06374030 is actively recruiting participants. Contact the research team at peter.veldhuis@mcl.nl for enrollment information.
Where is the NCT06374030 trial being conducted?
This trial is being conducted at Leeuwarden, Netherlands.
Who is sponsoring the NCT06374030 clinical trial?
NCT06374030 is sponsored by Frisius Medisch Centrum. The trial plans to enroll 1,000 participants.